Transition to a virtual multidisciplinary tumor board during the <scp>COVID</scp>‐19 pandemic: University of Pittsburgh experienceHarish Dharmarajan, Mark Kubik, Raja R. Seethala et al.|Head & Neck|2020Cited by 88
Poor treatment tolerance in head and neck cancer patients with low muscle massMarco A. Mascarella, Shaum Sridharan, Terral Patel et al.|Head & Neck|2022Cited by 20
Major head and neck reconstruction during the <scp>COVID</scp>‐19 pandemic: The University of Pittsburgh approachViran J. Ranasinghe, Mark Kubik, Leila J. Mady et al.|Head & Neck|2020Cited by 17
Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).Robert L. Ferris, Dan P. Zandberg, William E. Gooding et al.|Journal of Clinical Oncology|2023Cited by 17
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavityJoaquin E. Jimenez, Shaum Sridharan, Marci L. Nilsen et al.|Oral Oncology|2021Cited by 12